183540-38-7 Usage
Uses
Used in Pharmaceutical Synthesis:
(R)-(3-PYRROLIDINEOXY)TETRAHYDRO-2H-PYRAN is used as a building block for the synthesis of various pharmaceuticals, due to its unique stereochemical and structural properties that facilitate the creation of complex molecular structures.
Used in Agrochemical Development:
(R)-(3-PYRROLIDINEOXY)TETRAHYDRO-2H-PYRAN is used as an intermediate in the development of agrochemicals, contributing to the design and synthesis of novel compounds with potential applications in agriculture.
Used in Natural Product Synthesis:
(R)-(3-PYRROLIDINEOXY)TETRAHYDRO-2H-PYRAN is used as a key intermediate in the synthesis of natural products, allowing for the creation of complex molecules that can be found in various natural sources.
Used in Drug Development:
(R)-(3-PYRROLIDINEOXY)TETRAHYDRO-2H-PYRAN is used as a valuable tool in the development of new drugs, thanks to its unique stereochemistry and structural properties that can be exploited to design innovative therapeutic agents.
Used in Material Science:
(R)-(3-PYRROLIDINEOXY)TETRAHYDRO-2H-PYRAN is used as a component in the development of new materials, leveraging its structural properties to create novel materials with specific characteristics and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 183540-38-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,5,4 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 183540-38:
(8*1)+(7*8)+(6*3)+(5*5)+(4*4)+(3*0)+(2*3)+(1*8)=137
137 % 10 = 7
So 183540-38-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H17NO2/c1-2-6-11-9(3-1)12-8-4-5-10-7-8/h8-10H,1-7H2/t8-,9?/m1/s1
183540-38-7Relevant academic research and scientific papers
PROCESS FOR PREPARING 3-AMINOTHIENOPYRIDONE DERIVATIVES
-
Page 29, (2008/06/13)
This invention provides a class of 3-amino-7H-thieno[2,3-b]pyridin-6-one derivatives, substituted in the 7-position by an aryl, heteroaryl, cycloalkyl or heterocycloalkyl moiety, and in the 2-position by a specified range of substituent groups; also provided is a process for preparing those compounds, and the use thereof as intermediates in the manufacture of certain p38 MAP kinase inhibitors.
Pyrrolidinyl hydroxamic acid compounds and their production process
-
, (2008/06/13)
A compound of formula (I) STR1 and its pharmaceutically acceptable salt, wherein A is hydrogen or OY, wherein Y is a hydroxy protecting group; Ar is phenyl optionally substituted with one or more substituents selected from halo, hydroxy, C1 -C4 alkyl, C1 -C4 alkoxy, CF3, C1 -C4 alkoxy-C1 -C4 alkyloxy and carboxy-C1 -C4 alkyloxy; X is phenyl, naphthyl, biphenyl, indanyl, benzofuranyl, benzothiophenyl, 1-tetralone-6-yl,C1 -C4 alkylenedioxy, pyridyl, furyl and thienyl these groups optionally being substituted with up to three substituents selected from halo, C1 -C4 alkyl, C1 -C4 alkoxy, hydroxy, NO2, CF3 and SO2 CH3 ; and R is hydrogen, C1 -C4 alkyl or a hydroxy protecting group. These compounds and pharmaceutical compositions containing them are useful as analgesic, anti-inflammatory, diuretic, anesthetic or neuroprotective agents, or an agent for stroke or treatment of functional bowel diseases such as abdominal pain, for the treatment of a mammalian subject, especially a human subject. Further, the present invention provides processes for producing the hydroxamic compounds of formula (I) and their intermediate compounds of the formula. STR2
